Promoter hypermethylation of FBXO32, a novel TGF-β/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer.
| Title: | Promoter hypermethylation of FBXO32, a novel TGF-β/SMAD4 target gene and tumor suppressor, is associated with poor prognosis in human ovarian cancer. |
|---|---|
| Authors: | Jian-Liang Chou, Her-Young Su, Lin-Yu Chen, Yu-Ping Liao, Hartman-Frey, Corinna, Yi-Hui Lai, Hui-Wen Yang, Deatherage, Daniel E., Chieh-Ti Kuo, Yi-Wen Huang, Yan, Pearlly S., Shu-Huei Hsiao, Tai, Chien-Kuo, Lin, Huey-Jen L., Davuluri, Ramana V., Tai-Kuang Chao, Nephew, Kenneth P., Huang, Tim H.-M., Lai, Hung-Cheng, Chan, Michael W-Y |
| Source: | Laboratory Investigation (00236837); Mar2010, Vol. 90 Issue 3, p414-425, 12p, 2 Charts, 7 Graphs |
| Database: | Complementary Index |
Be the first to leave a comment!